Keytruda Before & After Sx Improves Outcomes in Early TNBC

moderators

Keytruda Before and After Surgery Improves Outcomes in Early-Stage Triple-Negative Breast Cancer
July 27, 2021
The immunotherapy medicine Keytruda plus chemotherapy before surgery and Keytruda alone after surgery improved event-free survival better than chemotherapy alone in women diagnosed with early-stage triple-negative breast cancer. Read more...